# A Prospective, Multicenter, Open-label Two Cohort Study Evaluating the Safety and Efficacy of Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres to Bridge or Downstage Patients With Hepatocellular Carcinoma (HCC) to Liver Transplant or Resection and Elicit Path

> clinical trial · VERIFIED · 2026-06-23

Status: NOT_YET_RECRUITING · Sponsor: Sirtex Medical · Condition: Hepatocellular Carcinoma (HCC)

- Company: Sirtex Medical
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07663487

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.